Composite plasma targets

The term Composite plasma targets does not refer to a single, specific molecular entity such as a receptor, enzyme, or transporter. Instead, it is a collective or aggregate designation used to describe a group of proteins, factors, or biomarkers found within blood plasma that are analyzed or targeted simultaneously. In clinical research and drug development, such terms are often used in the context of multi-analyte assays, plasma-derived therapies, or composite endpoints where the therapeutic effect is measured across several plasma constituents rather than a single protein. Because it lacks a specific UniProt ID or defined molecular structure, it is considered an incorrect or non-canonical target for drug discovery purposes. Analysts should identify the specific individual proteins within the plasma (such as Albumin, Coagulation Factors, or specific Cytokines) to understand the precise pharmacological mechanism and therapeutic relevance.

Other names

Plasma-derived targetsBlood plasma components

Not applicable as this is a non-specific aggregate term.